How This Evidence Evolved
Pancreaticoduodenectomy Volume-Outcome
The Relationship Between Hospital Volume and Surgical Mortality in Complex Cancer Operations
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Follow-up studies, subgroup analyses, and real-world validation
Operative mortality by surgeon volume — pancreatic resection mortality inversely correlated with individual surgeon volume
Pancreatectomy complications and 90-day mortality: high-volume surgeon/hospital OR 0.73 (95% CI 0.66–0.80) and OR 0.66 (95% CI 0.56–0.76), respectively.
In-hospital mortality: post-regionalization 2.6% vs historical cohort 24.4% (P<0.01).
Integration into clinical practice guidelines and recommendations
Current standard of care and ongoing research directions
Landmark Trials in This Story
Impact of hospital volume on operative mortality for major cancer surgery
Thirty-day mortality after pancreatectomy: low-volume 12.9% vs high-volume 5.8% (P=.004 for volume association).
Hospital volume and surgical mortality in the United States
Adjusted operative mortality after pancreatic resection: very-low-volume 16.3% vs very-high-volume 3.8%
Surgeon volume and operative mortality in the United States
Operative mortality by surgeon volume — pancreatic resection mortality inversely correlated with individual surgeon volume
Variation in outcomes across surgeons meeting the Leapfrog volume standard for complex oncologic surgery.
Pancreatectomy complications and 90-day mortality: high-volume surgeon/hospital OR 0.73 (95% CI 0.66–0.80) and OR 0.66 (95% CI 0.56–0.76), respectively.
Reduction of in-hospital mortality following regionalisation of pancreatic surgery in the south-east of the Netherlands.
In-hospital mortality: post-regionalization 2.6% vs historical cohort 24.4% (P<0.01).
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.